Therefore, our study provides some new insights into understanding the molecular mechanisms underlying hepatocellular carcinogenesis, implying that DEPDC1 may be used as a promising candidate therapeutic target against HCC. The gene discussed is DEPDC1; the disease is hepatocellular carcinoma.